German-Chinese cooperation

ISAS Participates in Drug Development for Heart Patients

Dortmund, 5th February 2020

The development of a new drug for the treatment of heart failure and cardiac hypertrophy is a primary goal of “ChInValue – NRW–China Cooperations: GRK5 Inhibitors”. The project is being coordinated by the Lead Discovery Center (LDC) and conducted in cooperation with the Leibniz Institute for Analytical Sciences (ISAS) and two Chinese partners: Shanghai Jemincare Pharmaceutical Co. and Makohs Biotech. The German–Chinese consortium will devote itself to the fight against cardiac insufficiency and hypertrophy until the end of 2022. The German partners are being funded by a grant of around EUR 1 million from the German Federal Ministry of Education and Research (BMBF).

Die Arbeiten des Konsortiums werden sich auf die Proteinkinase GRK5 fokussieren, welche bisher in der Arzneimittelentwicklung wenig beachtet wurde. — Research will focus on GRK5, a protein kinase that has so far received little attention in drug development, despite being implicated in the development of heart failure or hypertrophic heart muscle in the vast majority of cases.

Research will focus on GRK5, a protein kinase that has so far received little attention in drug development, despite being implicated in the development of heart failure or hypertrophic heart muscle in the vast majority of cases. The aim of the project is to develop low-molecular-weight substances that inhibit the pathological processes mediated by GRK5.

“Our ambitious goal is to develop a drug candidate that is ready to enter preclinical development by the end of this three-year project,” says LDC’s Managing Director and CSO, Dr Bert Klebl.

“We hope to develop an effective new therapy from which heart disease patients can profit in the near future,” explains the ISAS scientific director and head of the Biomedical Research Department, Prof. Kristina Lorenz, a pharmacologist specializing in the treatment of cardiovascular diseases.

Financial support is being provided by the German Federal Ministry of Education and Research as part of its funding programme “InterSPIN – internationalization of leading-edge clusters, forward-looking projects and comparable networks”. Within this context, BIO.NRW and BIO Clustermanagement NRW GmbH have conceived and realized the internationalization alliance „NRW-China Cooperations: A strategic perspective for innovative life science SME value chains”, of which this project in the fight against heart failure is a part.

Further press releases

23rd April 2024

A cause of immunodeficiency identified

After a stroke or heart attack, the immune system of those affected is often impaired. This can lead to life-threatening infections. A team of researchers from the Faculty of Medicine at the University of Duisburg-Essen, Essen University Hospital and ISAS, has now discovered a previously unknown cause for the connection between stroke, heart attack and immunodeficiency. But that's not all: the team has also identified a new treatment approach.

Fluoreszenz-Ultramikroskopische Aufnahme aus dem speziellen Darmgewebe einer Maus, das besonders viele Ig-produzierende Plasmazellen enthält.

24th January 2024

EfficientBioAI: New Open-Source Software Makes AI Models Lighter and Greener

Artificial intelligence has become an integral part of research. However, the better and more complex the models become, the higher their energy consumption. Researchers at ISAS and Peking University have therefore developed ready-to-use and open software that compresses existing bioimaging AI models. With the help of the new toolbox, scientists can now run their models faster and with significantly lower energy consumption.

Die Abbildung zeigt die 3D-Semantiksegmentierung von Osteozyten in Mäuseknochen vor und nach der Kompression des Modells mir EfficientBioAI Die Bilder wurden mittels Lichtblatt-Fluoreszenzmikroskopie aufgenommen.

11th December 2023

ComplexEye & AI Enable Faster Migration Analysis of Immune Cells

How and where immune cells such as neutrophil granulocytes migrate, for instance whether they infiltrate tumours, is crucial for cancer patients. They could benefit from drugs that prevent this migration. Until now, the migration behaviour of immune cells could only be investigated using conventional video microscopy. However, researchers at the University of Duisburg-Essen and ISAS have now developed the ComplexEye. With their new microscope for the high-throughput analysis of drug substances, they are now able to analyse significantly higher numbers of neutrophils for their migration behaviour.

Vergleich ComplexEye-Objektiv und 28,5-mm-Objektiv eines konventionellen Mikroskops.

11th November 2022

Chan Zuckerberg Initiative Funds Two Projects from Dortmund

To extend the image analysis platform napari, Chan Zuckerberg Initiative is funding two projects of the ISAS research groups AMBIOM - Analysis of Microscopic BIOMedical Images and Spatial Metabolomics.

Die linke Abbildung zeigt eine Mikroskop-Aufnahme von Tumor-Zellen. Auf der rechten Seite ist die Segmentierung mittels gängiger Computerprogramme zu sehen. Sobald die Zellen dicht nebeneinander liegen oder überlappen (s. blaue Markierung) verschlechtert sich die Segmentierung. Das vollautomatische Tracking führt daher im Ergebnis zu Ungenauigkeiten.

18th November 2021

Kristina Lorenz Wins Phoenix Prize

Prof. Dr. Kristina Lorenz and her team found a peptide agent against heart failure. For this achievment, Lorenz has been awarded the Phoenix Pharmacy Prize in the category "Pharmacology and Clinical Pharmacy".

Die Würzburger Professorin Kristina Lorenz mit den drei anderen Trägern des 2021er Phoenix Pharmazie-Wissenschaftspreises.

20th September 2021

New AMBIOM Group: Jianxu Chen Wants to Develop „Eyes & Brains“

Led by Dr Jianxu Chen, the junior research group AMBIOM plans to develop algorithms and methods that will allow countless image data worldwide to be analysed automatically, quickly and economically.

Dr. Jianxu Chen hat seine Forschungsarbeit am ISAS aufgenommen.